Army develops COVID-19 vaccine that may provide protection against all variants
Fox News
Test results against some variants have provided positive results, but researchers have yet to test against omicron.
Researchers received a sample in early 2020 and focused efforts on developing a vaccine that would work against potential variants. Two years later, the initial results show promise.
The phase 1 human trials commenced April 2021. Scientists hailed the early data as encouraging and will publish final phase 1 study results once they complete the analysis.
More Related News